Thanks! You've successfully subscribed to the BONEZONE®/OMTEC® Monthly eNewsletter!

Please take a moment to tell us more about yourself and help us keep unwanted emails out of your inbox.

Choose one or more mailing lists:
BONEZONE/OMTEC Monthly eNewsletter
OMTEC Conference Updates
Advertising/Sponsorship Opportunities
Exhibiting Opportunities
* Indicates a required field.

Orchid Appoints Josh Pang as Chief Commercial Officer

        Josh Pang, Orchid Orthopedic Solutions
        Josh Pang, Orchid
Orthopedic Solutions

Orchid Orthopedic Solutions announced that Josh Pang joined the company as Chief Commercial Officer on February 1, 2021.

Mr. Pang comes to Orchid from ConMed, where he held roles of increasing responsibility and influence. He most recently held the role of Vice President of Orthopedic Sales, where he was responsible for managing the U.S. salesforce. He has experience in growing market share through relationship building and concentrated execution. Previous to ConMed, he held various roles at Smith and Nephew, Pfizer and J&J.

Mr. Pang's appointment at Orchid was preceded in late 2020 by the selection of Nate Folkert to succeed Jerry Jurkiewicz as Chief Executive Officer. Mr. Folkert's previous role was as Vice President & General Manager for ConMed’s orthopedic business.

“One of the key enablers of Orchid’s business strategy is a focus on our customers. We know that having a strong relationship with our customers helps drive growth. To continue building on our foundation of customer relationships, I am pleased to announce the addition of Josh Pang to the Orchid Leadership Team,” said Mr. Folkert.

As a strategic sourcing partner, Orchid is a global supplier of orthopedic medical device outsourcing, providing contract design and manufacturing services.